Search research articles
Contact Us
Filters
Showing results (71-80 of 82) with videos related to
Page
of 9
Sort By:
Archives of Pathology & Laboratory Medicine
|
August 6, 2009
Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the International Mesothelioma Interest Group
Aliya N Husain, Thomas V Colby, Nelson G Ordóñez, et al.
The American Journal of Surgical Pathology
|
January 26, 2011
Pure epithelioid PEComas (so-called epithelioid angiomyolipoma) of the kidney: A clinicopathologic study of 41 cases: detailed assessment of morphology and risk stratification
Nalan Nese, Guido Martignoni, Christopher D Fletcher, et al.
Plos One
|
March 24, 2015
Personalized oncogenomics: clinical experience with malignant peritoneal mesothelioma using whole genome sequencing
Brandon S Sheffield, Anna V Tinker, Yaoqing Shen, et al.
Journal of the National Cancer Institute
|
November 9, 2013
An international Ki67 reproducibility study
Mei-Yin C Polley, Samuel C Y Leung, Lisa M McShane, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
August 15, 2019
Quantitative assessment of PD-L1 as an analyte in immunohistochemistry diagnostic assays using a standardized cell line tissue microarray
Sandra Martinez-Morilla, John McGuire, Patricia Gaule, et al.
Cancer Research
|
January 18, 2008
Antibody-mediated blockade of integrin alpha v beta 6 inhibits tumor progression in vivo by a transforming growth factor-beta-regulated mechanism
Louise A Koopman Van Aarsen, Diane R Leone, Steffan Ho, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM
|
April 14, 2009
Implementation of a Canadian external quality assurance program for breast cancer biomarkers: an initiative of Canadian Quality Control in immunohistochemistry (cIQc) and Canadian Association of Pathologists (CAP) National Standards Committee/Immunohistochemistry
Jefferson Terry, Emina Emilia Torlakovic, John Garratt, et al.
Archives of Pathology & Laboratory Medicine
|
July 8, 2017
Guidelines for Pathologic Diagnosis of Malignant Mesothelioma 2017 Update of the Consensus Statement From the International Mesothelioma Interest Group
Aliya Noor Husain, Thomas V Colby, Nelson G Ordóñez, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
February 21, 2015
An international study to increase concordance in Ki67 scoring
Mei-Yin C Polley, Samuel C Y Leung, Dongxia Gao, et al.
NPJ Breast Cancer
|
July 20, 2017
Analytical validation of a standardized scoring protocol for Ki67: phase 3 of an international multicenter collaboration
Samuel C Y Leung, Torsten O Nielsen, Lila Zabaglo, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 82) with videos related to
Sort By:
Page
of 9
Archives of Pathology & Laboratory Medicine
|
August 6, 2009
Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the International Mesothelioma Interest Group
Aliya N Husain, Thomas V Colby, Nelson G Ordóñez, et al.
The American Journal of Surgical Pathology
|
January 26, 2011
Pure epithelioid PEComas (so-called epithelioid angiomyolipoma) of the kidney: A clinicopathologic study of 41 cases: detailed assessment of morphology and risk stratification
Nalan Nese, Guido Martignoni, Christopher D Fletcher, et al.
Plos One
|
March 24, 2015
Personalized oncogenomics: clinical experience with malignant peritoneal mesothelioma using whole genome sequencing
Brandon S Sheffield, Anna V Tinker, Yaoqing Shen, et al.
Journal of the National Cancer Institute
|
November 9, 2013
An international Ki67 reproducibility study
Mei-Yin C Polley, Samuel C Y Leung, Lisa M McShane, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
August 15, 2019
Quantitative assessment of PD-L1 as an analyte in immunohistochemistry diagnostic assays using a standardized cell line tissue microarray
Sandra Martinez-Morilla, John McGuire, Patricia Gaule, et al.
Cancer Research
|
January 18, 2008
Antibody-mediated blockade of integrin alpha v beta 6 inhibits tumor progression in vivo by a transforming growth factor-beta-regulated mechanism
Louise A Koopman Van Aarsen, Diane R Leone, Steffan Ho, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM
|
April 14, 2009
Implementation of a Canadian external quality assurance program for breast cancer biomarkers: an initiative of Canadian Quality Control in immunohistochemistry (cIQc) and Canadian Association of Pathologists (CAP) National Standards Committee/Immunohistochemistry
Jefferson Terry, Emina Emilia Torlakovic, John Garratt, et al.
Archives of Pathology & Laboratory Medicine
|
July 8, 2017
Guidelines for Pathologic Diagnosis of Malignant Mesothelioma 2017 Update of the Consensus Statement From the International Mesothelioma Interest Group
Aliya Noor Husain, Thomas V Colby, Nelson G Ordóñez, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
February 21, 2015
An international study to increase concordance in Ki67 scoring
Mei-Yin C Polley, Samuel C Y Leung, Dongxia Gao, et al.
NPJ Breast Cancer
|
July 20, 2017
Analytical validation of a standardized scoring protocol for Ki67: phase 3 of an international multicenter collaboration
Samuel C Y Leung, Torsten O Nielsen, Lila Zabaglo, et al.
Page
of 9